Urogen Pharma Ltd
(URGN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 37,354 | 56,221 | 29,498 | 81,501 | 105,929 |
| Marketable Securities | 28,514 | 44,556 | 67,225 | 31,048 | 31,065 |
| Receivables | 12,493 | 12,704 | 9,429 | 11,595 | 9,499 |
| Inventories | 5,466 | 4,325 | 4,862 | 5,047 | 4,756 |
| TOTAL | $95,973 | $128,907 | $121,594 | $139,624 | $160,524 |
| Non-Current Assets | |||||
| PPE Net | 1,103 | 1,297 | 1,519 | 1,605 | 1,777 |
| Investments And Advances | 10,165 | 0 | 0 | 673 | 674 |
| Other Non-Current Assets | 5,713 | 5,415 | 5,360 | 4,239 | 2,740 |
| TOTAL | $16,981 | $6,712 | $6,879 | $6,517 | $5,191 |
| Total Assets | $112,954 | $135,619 | $128,473 | $146,141 | $165,715 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 17,130 | 12,383 | 9,356 | 8,647 | 9,936 |
| Accrued Expenses | 4,919 | 8,257 | 6,625 | 6,428 | 5,146 |
| Other current liabilities | 3,185 | 3,276 | 3,018 | 2,965 | 4,009 |
| TOTAL | $25,234 | $23,916 | $18,999 | $18,040 | $19,091 |
| Non-Current Liabilities | |||||
| Long Term Debt | 97,941 | 97,537 | 71,870 | 71,196 | 70,797 |
| Other Non-Current Liabilities | 106,333 | 103,527 | 100,890 | 97,818 | 92,901 |
| TOTAL | $204,274 | $201,064 | $172,760 | $169,014 | $163,698 |
| Total Liabilities | $229,508 | $224,980 | $191,759 | $187,054 | $182,789 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 23,454 | 23,441 | 23,090 | 22,741 | 22,693 |
| Common Shares | 64 | 63 | 63 | 62 | 62 |
| Retained earnings | -607,317 | -577,104 | -548,235 | -522,404 | -495,713 |
| Other shareholders' equity | -45 | -107 | -155 | -56 | -69 |
| TOTAL | $-116,554 | $-89,361 | $-63,286 | $-40,913 | $-17,074 |
| Total Liabilities And Equity | $112,954 | $135,619 | $128,473 | $146,141 | $165,715 |